Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pongs+zahn Inh.gen.unb. buy krebskrebs

Start price
€0.007
28.04.20 / 50%
Target price
€0.30
04.11.21
Performance (%)
-57.14%
End price
€0.003
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €0.003. The BUY prediction by krebskrebs for Pongs+zahn Inh.gen.unb. performed very badly with a performance of -57.14%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Pongs+zahn Inh.gen.unb. - - - -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

Comments by krebskrebs for this prediction

In the thread Pongs+zahn Inh.gen.unb. diskutieren
Prediction Buy
Perf. (%) -57.14%
Target price 0.300
Change
Ends at 04.11.21

Buy mit Kursziel 0,3

In the thread Trading Pongs+zahn Inh.gen.unb.
Prediction Buy
Perf. (%) -57.14%
Target price 0.300
Change
Ends at 04.11.21

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten